LMAT LeMaitre Vascular
- 91.710
- +1.420+1.57%
- 91.710
- 0.0000.00%
LeMaitre Vascular News
LeMaitre Vascular Analyst Ratings
Barrington Research Maintains Outperform on LeMaitre Vascular, Maintains $92 Price Target
Barrington Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Maintains Target Price $92
Lemaitre Vascular's Growth Prospects Bolstered by Pricing Power and Strategic Expansion: A Buy Rating Review
Lake Street Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Maintains Target Price $105
Lemaitre Vascular (LMAT) Gets a Buy From Lake Street
JMP Securities Maintains Market Outperform on LeMaitre Vascular, Raises Price Target to $100
LeMaitre Vascular Analyst Ratings
JMP Securities Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Raises Target Price to $100
Lemaitre Vascular's Strong Financial Performance and Growth Potential Warrant a Buy Rating
A Quick Look at Today's Ratings for LeMaitre Vascular(LMAT.US), With a Forecast Between $92 to $105
LeMaitre Vascular Analyst Ratings
Barrington Research Maintains Outperform on LeMaitre Vascular, Raises Price Target to $92
Buy Rating Affirmed for Lemaitre Vascular Amid Strong Fiscal Performance and Growth Prospects
Stifel Nicolaus Reaffirms Their Buy Rating on Lemaitre Vascular (LMAT)
Roth MKM Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Maintains Target Price $100
Stifel Maintains LeMaitre Vascular(LMAT.US) With Buy Rating, Raises Target Price to $95
KeyBanc Maintains LeMaitre Vascular(LMAT.US) With Hold Rating
Lemaitre Vascular (LMAT) Receives a Hold From KeyBanc
Lemaitre Vascular's Strong Performance and Promising Outlook Underpin Buy Rating
Analysis
Price Target
No Data
No Data